Emcure Pharma IPO: Namita Thappar On Tie Up With Sanofi & In-House Products For Cardiac Segment

Namita Thappar, in association with Sanofi, has strategically partnered for Emcure Pharmaceuticals, aiming to leverage their combined expertise in cardiovascular healthcare. Additionally, she is spearheading the development of innovative in-house products dedicated to enhancing cardiovascular treatments, thereby reinforcing Emcure Pharmaceuticals' commitment to advancing healthcare solutions.
#emcurepharma #namitathapar #ipo
-------------------------------------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: / @ndtvprofitindia
Visit NDTV Profit for more news: www.ndtvprofit.com/
Don't enter the stock market unaware. Read all Research Reports here: www.ndtvprofit.com/research-r...
Follow NDTV Profit here
Twitter: / ndtvprofitindia , / ndtvprofit
LinkedIn: / ndtvprofit
Instagram: / ndtvprofit
Facebook: / ndtvprofit